Prosight Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-196,257
Closed -$1.04M 50
2022
Q3
$1.04M Sell
196,257
-144,851
-42% -$765K 0.56% 32
2022
Q2
$1.45M Buy
341,108
+15,743
+5% +$66.7K 1.14% 18
2022
Q1
$1.14M Buy
325,365
+271,550
+505% +$953K 0.74% 24
2021
Q4
$358K Buy
+53,815
New +$358K 0.21% 32